Primary Site >> Colorectal Cancer
Gene >> APOB
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Biosynthetic precursor (214 kDa) of apolipoprotein B-48 is not secreted by Caco-2 cells and normal human intestine. PMID: 2604723 |
Ref: Similarities and differences in the function of regulatory elements at the 5' end of the human apolipoprotein B gene in cultured hepatoma (HepG2) and colon carcinoma (CaCo-2) cells. PMID: 1660892 |
Ref: Nuclease-hypersensitive sites define a region with enhancer activity in the third intron of the human apolipoprotein B gene. PMID: 1527004 |
Ref: The mechanism by which the human apolipoprotein B gene reducer operates involves blocking of transcriptional activation by hepatocyte nuclear factor 3. PMID: 8441395 Ref: Increased expression of apolipoprotein genes accompanies differentiation in the intestinal cell line Caco-2. PMID: 8516325 |
Ref: Caco-2 cells as a model for intestinal lipoprotein synthesis and secretion. PMID: 7768354 |
Ref: Assembly and secretion of VLDL in nondifferentiated Caco-2 cells stably transfected with human recombinant ApoB48 cDNA. PMID: 9409282 |
Ref: Apolipoprotein B, a paradigm for proteins regulated by intracellular degradation, does not undergo intracellular degradation in CaCo2 cells. PMID: 10660549 |
Ref: Apobec-1 transcription in rat colon cancer: decreased apobec-1 protein production through alterations in polysome distribution and mRNA translation associated with upstream AUGs. PMID: 12020819 Ref: Chronic but not acute treatment with conjugated linoleic acid (CLA) isomers (trans-10, cis-12 CLA and cis-9, trans-11 CLA) affects lipid metabolism in Caco-2 cells. PMID: 12163657 |
Ref: Inhibiting proteasomal degradation of microsomal triglyceride transfer protein prevents CCl4-induced steatosis. PMID: 17405876 Ref: Mechanisms involved in vitamin E transport by primary enterocytes and in vivo absorption. PMID: 17582142 |
Ref: Tissue expression of glycated apolipoprotein B in colorectal adenoma and cancer. PMID: 21378338 Ref: Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition. PMID: 21383385 |
Ref: Serum Lipids and the Risk of Gastrointestinal Malignancies in the Swedish AMORIS Study. PMID: 22969802 |
Ref: [Experimental study of the impact of hyperlipidemia on the chemotherapy in colorectal cancer model]. PMID: 23801216 |
Ref: Effect of onion flavonoids on colorectal cancer with hyperlipidemia: an in vivo study. PMID: 24470761 Ref: Lipid levels in serum and cancerous tissues of colorectal cancer patients. PMID: 25024621 |
Ref: Apolipoproteins, lipids and risk of cancer. PMID: 26804063 Ref: Predictive value of chemotherapy-related high-density lipoprotein cholesterol (HDL) elevation in patients with colorectal cancer receiving adjuvant chemotherapy: an exploratory analysis of 851 cases. PMID: 27344180 |
Ref: Decreased serum apolipoprotein A1 levels are associated with poor survival and systemic inflammatory response in colorectal cancer. PMID: 28710487 Ref: Blood lipids and lipoproteins in relation to incidence and mortality risks for CVD and cancer in the prospective EPIC-Heidelberg cohort. PMID: 29254484 |
Ref: Intestinal microorganisms involved in colorectal cancer complicated with dyslipidosis. PMID: 30239257 |